肺表面活性物质联合气道正压通气预防极低出生体重儿呼吸窘迫综合征  

Study on prevention of respiratory distress syndrome of very low birth weight infants by pulmonary surfactant and positive airway pressure

作　　者：倪艳[1] 于鸿[1] 

机构地区：[1]吉林油田总医院,吉林松原138000

出　　处：《中国妇幼保健》2009年第35期5079-5080,共2页Maternal and Child Health Care of China

摘　　要：目的:探讨肺表面活性物质联合经鼻持续气道正压通气对极低出生体重新生儿呼吸窘迫综合症的预防价值。方法:将2005年1月～2007年12月收住医院的极低出生体重儿73例按是否早期使用肺表面活性物质分为预防组(33例)和对照组(40例),比较其NRDS及并发症的发病率。结果:预防组的NRDS发病率及并发症的发生率较对照组明显降低(P<0.05)。结论:早期使用PS并联合经鼻持续气道正压通气可有效预防极低出生体重儿NRDS的发病率,并改善NRDS的治疗效果。Objective： To explore the value of pulmonary surfactant and positive airway pressure in prevention of respiratory dis tress syndrome of very low birth weight infants, Methods： 73 very low birth weight infants were divided into prevention group （33 infants） and control group （40 infants） according to usage of pulmonary surfactant or not from January 2005 to December 2007. The incidences of respiratory distress syndrome and complications were compared. Results： The incidences of respiratory distress syndrome and complications in prevention group were significantly lower than those in control group （P 〈 0. 05 ） . Conclusion： Pulmonary surfactant and positive airway pressure can reduce the incidence of respiratory distress syndrome of very low birth weight infants effectively and improve clinical efficacy.

关 键 词：肺表而活性物质 气道正庄通气 极低出生体重儿 新生儿呼吸窘迫综合征 

分 类 号：R722.1[医药卫生—儿科]